Author: Recalde, Borja; GarcÃa-Tobar, Laura; Argueta, Alan; Ãlvarez, Laura; De Andrea, Carlos Eduardo; Fernández Alonso, Mirian; Ezponda, Ana; Carmona Torre, Francisco; Jordán Iborra, Carlota; Quiroga, Jorge Augusto; Del Pozo, Jose Luis; Zulueta, Javier J; Echarri, Gema; Landecho, Manuel F; Lozano, Maria Dolores
Title: Histopathological findings in fatal COVID-19 severe acute respiratory syndrome: preliminary experience from a series of 10 Spanish patients Cord-id: jcgc93it Document date: 2020_8_23
ID: jcgc93it
Snippet: In December 2019, an outbreak of severe acute respiratory syndrome associated to SARS-CoV2 was reported in Wuhan, China. To date, little is known on histopathological findings in patients infected with the new SARS-CoV2. Lung histopathology shows features of acute and organising diffuse alveolar damage. Subtle cellular inflammatory infiltrate has been found in line with the cytokine storm theory. Medium-size vessel thrombi were frequent, but capillary thrombi were not present. Despite the elevat
Document: In December 2019, an outbreak of severe acute respiratory syndrome associated to SARS-CoV2 was reported in Wuhan, China. To date, little is known on histopathological findings in patients infected with the new SARS-CoV2. Lung histopathology shows features of acute and organising diffuse alveolar damage. Subtle cellular inflammatory infiltrate has been found in line with the cytokine storm theory. Medium-size vessel thrombi were frequent, but capillary thrombi were not present. Despite the elevation of biochemical markers of cardiac injury, little histopathological damage could be confirmed. Viral RNA from paraffin sections was detected at least in one organ in 90% patients.
Search related documents:
Co phrase search for related documents- acute phase and low molecular weight heparin: 1, 2, 3, 4, 5, 6
- acute phase and lung biopsy: 1, 2, 3, 4
- acute phase and lung damage: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20
- acute phase and lung damage histopathology: 1, 2
- acute phase and lung sample: 1
- acute phase and lung tissue: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24
- acute sars infection and low molecular weight: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18
- acute sars infection and low molecular weight heparin: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13
- acute sars infection and lung biopsy: 1
- acute sars infection and lung damage: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37
- acute sars infection and lung prevalent: 1
- acute sars infection and lung tissue: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33
- low molecular weight and lung damage: 1, 2, 3, 4, 5, 6, 7
- low molecular weight and lung tissue: 1, 2, 3, 4, 5, 6
- low molecular weight heparin and lung damage: 1, 2, 3, 4, 5
- low molecular weight heparin and lung tissue: 1, 2
- lung damage and lymphocytic infiltrate: 1
- lung tissue and lymphocytic infiltrate: 1
Co phrase search for related documents, hyperlinks ordered by date